The Valley Desk

NCT02760433 · Interventional trial

Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease

Overall registry status Completed

Phase 3

Conditions Rheumatoid Arthritis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov